# Pymaceuticals Inc. 
## Analyzing data from the recentmost animal study
Pymaceuticals Inc., a burgeoning pharmaceutical company based in San Diego, specializes in anti-cancer pharmaceuticals. Recently, Pymaceuticals Inc. began screening for potential treatments for **squamous cell carcinoma (SCC)**, a commonly occurring form of skin cancer.  
In their most recent animal study, **_250 mice_** identified with SCC tumor growth were treated through a variety of drug regimens. Over the course of 45 days, tumor development was observed and measured. The purpose of the study was to compare the performance of Pymaceuticals' drug of interest, **Capomulin**, versus the other treatment regimens. As tasked by the executive team, the analysis is summarized in a technical report (Pymaceuticals Report.pdf) which also includes colorful visuals related to the study. 
### Business Problem study 
**_What are the meaningful insights regarding the performance of an anti-cancer drug Capomulin gained from a recent animal study?_**
